Antti Iitiä

913 total citations
23 papers, 738 citations indexed

About

Antti Iitiä is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antti Iitiä has authored 23 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antti Iitiä's work include Advanced biosensing and bioanalysis techniques (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and Molecular Biology Techniques and Applications (3 papers). Antti Iitiä is often cited by papers focused on Advanced biosensing and bioanalysis techniques (6 papers), DNA and Nucleic Acid Chemistry (5 papers) and Molecular Biology Techniques and Applications (3 papers). Antti Iitiä collaborates with scholars based in Finland, United States and Sweden. Antti Iitiä's co-authors include Timo Lövgren, Minna Sjöroos, Helena Reijonen, Jorma Ilonen, Patrik Dahlén, Marek Kwiatkowski, Kim Pettersson, Toni Torresani, Riitta Veijola and Elja Herva and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Analytical Biochemistry.

In The Last Decade

Antti Iitiä

23 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antti Iitiä Finland 16 294 261 173 152 88 23 738
Yuhua Zhang China 17 51 0.2× 253 1.0× 19 0.1× 102 0.7× 81 0.9× 63 873
Junko Amano Japan 19 75 0.3× 746 2.9× 23 0.1× 51 0.3× 50 0.6× 38 1.0k
Sonia Facchin Italy 18 190 0.6× 557 2.1× 45 0.3× 134 0.9× 5 0.1× 54 1.0k
John A. Shupe United States 11 60 0.2× 236 0.9× 37 0.2× 52 0.3× 102 1.2× 16 526
Ewa E. Hennig Poland 20 94 0.3× 501 1.9× 36 0.2× 380 2.5× 64 0.7× 50 1.1k
G T Williams United Kingdom 8 428 1.5× 263 1.0× 28 0.2× 257 1.7× 11 0.1× 11 941
Jee H. Lee United States 14 157 0.5× 172 0.7× 84 0.5× 178 1.2× 60 0.7× 15 846
Mark K. Haynes United States 13 48 0.2× 199 0.8× 14 0.1× 57 0.4× 33 0.4× 28 621
Muhammad Naeem Pakistan 17 123 0.4× 294 1.1× 18 0.1× 43 0.3× 14 0.2× 87 777
Yuan Hu China 20 45 0.2× 526 2.0× 13 0.1× 70 0.5× 61 0.7× 67 1.3k

Countries citing papers authored by Antti Iitiä

Since Specialization
Citations

This map shows the geographic impact of Antti Iitiä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Iitiä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Iitiä more than expected).

Fields of papers citing papers by Antti Iitiä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antti Iitiä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Iitiä. The network helps show where Antti Iitiä may publish in the future.

Co-authorship network of co-authors of Antti Iitiä

This figure shows the co-authorship network connecting the top 25 collaborators of Antti Iitiä. A scholar is included among the top collaborators of Antti Iitiä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antti Iitiä. Antti Iitiä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfredsson, Gunnel, Saskia S. Sterk, Marco Blokland, et al.. (2004). Prevalence of zeranol, taleranol andFusariumspp. toxins in urine: implications for the control of zeranol abuse in the European Union. Food Additives & Contaminants. 21(9). 833–839. 23 indexed citations
2.
Cooper, K, Gunnel Alfredsson, Timo Lövgren, et al.. (2003). Interlaboratory ring test of time-resolved fluoroimmunoassays for zeranol and α-zearalenol and comparison with zeranol test kits. Food Additives & Contaminants. 20(9). 804–812. 8 indexed citations
3.
Sjöroos, Minna, Åke Lundwall, Matti Karp, et al.. (1999). Quantitative Reverse Transcription-PCR Assay with an Internal Standard for the Detection of Prostate-specific Antigen mRNA. Clinical Chemistry. 45(9). 1397–1407. 35 indexed citations
4.
Nilsson, Christel, Min Jiang, Kim Pettersson, et al.. (1998). Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clinical Endocrinology. 49(3). 369–376. 43 indexed citations
5.
Lövgren, Timo, Harri Hakala, Harri Takalo, et al.. (1997). Sensitive bioaffinity assays with individual microparticles and time-resolved fluorometry. Clinical Chemistry. 43(10). 1937–1943. 27 indexed citations
7.
Iitiä, Antti, et al.. (1997). Simple triple-label detection of seven cystic fibrosis mutations by time-resolved fluorometry. Clinical Chemistry. 43(7). 1142–1150. 26 indexed citations
9.
Ilonen, Jorma, Helena Reijonen, Elja Herva, et al.. (1996). Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish Population. Diabetes Care. 19(8). 795–800. 114 indexed citations
10.
Sjöroos, Minna, Antti Iitiä, Jorma Ilonen, Helena Reijonen, & Timo Lövgren. (1995). Triple-label hybridization assay for type-1 diabetes-related HLA alleles.. PubMed. 18(5). 870–7. 145 indexed citations
11.
Petersen, Niels Erik, et al.. (1995). Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism. Clinical Chemistry. 41(3). 413–418. 21 indexed citations
12.
Huoponen, Kirsi, Vesa Juvonen, Antti Iitiä, et al.. (1994). Time-resolved fluorometry in the diagnosis of Leber hereditary optic neuroretinopathy. Human Mutation. 3(1). 29–36. 10 indexed citations
13.
Eskola, Jarkko, Mauri M. Hämäläinen, V. Näntö, et al.. (1994). Detection of Philadelphia chromosome using PCR and europium-labeled DNA probes. Clinical Biochemistry. 27(5). 373–379. 7 indexed citations
14.
Vihinen, Mauno, et al.. (1994). C-terminal truncations of a thermostable Bacillus stearothermophilus α-amylase. Protein Engineering Design and Selection. 7(10). 1255–1259. 29 indexed citations
15.
Dahlén, Patrik, Marek Kwiatkowski, Pertti Hurskainen, et al.. (1994). Europium-Labeled Oligonucleotide Hybridization Probes: Preparation and Properties. Bioconjugate Chemistry. 5(3). 268–272. 18 indexed citations
16.
Eggertsen, Gösta, Mats Eriksson, Olov Wiklund, et al.. (1994). Time-resolved fluorometry in the genetic diagnosis of familial defective apolipoprotein B-100.. Journal of Lipid Research. 35(8). 1505–1508. 7 indexed citations
17.
Iitiä, Antti, Patrik Dahlén, Michael Nunn, Veli-Matti Mukkala, & Harri Siitari. (1992). Detection of amplified HTLV-I/-II viral sequences using time-resolved fluorometry. Analytical Biochemistry. 202(1). 76–81. 8 indexed citations
18.
Iitiä, Antti, Estrid Høgdall, Patrik Dahlén, et al.. (1992). Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry.. Genome Research. 2(2). 157–162. 17 indexed citations
19.
Dahlén, Patrik, et al.. (1991). Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence-based hybridization assay. Journal of Clinical Microbiology. 29(4). 798–804. 49 indexed citations
20.
Dahlén, Patrik, Antti Iitiä, Veli-Matti Mukkala, Pertti Hurskainen, & Marek Kwiatkowski. (1991). The use of europium (Eu3+) labelled primers in PCR amplification of specific target DNA. Molecular and Cellular Probes. 5(2). 143–149. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026